Limited mutagenesis increases the stability of human carboxypeptidase U (TAFIa) and demonstrates the importance of CPU stability over proCPU concentration in down-regulating fibrinolysis-Reference-Cited by-同舟云学术

Limited mutagenesis increases the stability of human carboxypeptidase U (TAFIa) and demonstrates the importance of CPU stability over proCPU concentration in down-regulating fibrinolysis

Published:2006-02 Issue:4 Volume:273 Page:778-792
ISSN:1742-464X
Container-title:FEBS Journal
language:en
Short-container-title:FEBS Journal

Author:

Knecht Wolfgang,Willemse Johan,Stenhamre Hanna,Andersson Mats,Berntsson Pia,Furebring Christina,Harrysson Anna,Hager Ann-Christin Malmborg,Wissing Britt-Marie,Hendriks Dirk,Cronet Philippe

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1742-4658.2006.05110.x/fullpdf

Reference40 articles.

1. Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U)

2. New insights into factors affecting clot stability: a role for thrombin activatable fibrinolysis inhibitor (TAFI; plasma procarboxypeptidase B, plasma procarboxypeptidase U, procarboxypeptidase R)

3. Thrombin and Fibrinolysis

4. arboxypeptidase U at the Interface Between Coagulation and Fibrinolysis

5. Isolation, molecular cloning, and partial characterization of a novel carboxypeptidase B from human plasma.

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ATOR-1017 (evunzekibart), an Fc-gamma receptor conditional 4-1BB agonist designed for optimal safety and efficacy, activates exhausted T cells in combination with anti-PD-1;Cancer Immunology, Immunotherapy;2023-10-05

2. Thrombin Activatable Fibrinolysis Inhibitor (TAFI): An Updated Narrative Review;International Journal of Molecular Sciences;2021-04-01

3. Estudio de la actividad del inhibidor de la fibrinólisis activable por trombina (TAFI), en plasma de pacientes con generación de trombina disminuida;Investigación Clínica;2019-07-01

4. Elucidation of the molecular mechanisms of two nanobodies that inhibit thrombin-activatable fibrinolysis inhibitor activation and activated thrombin-activatable fibrinolysis inhibitor activity;Journal of Thrombosis and Haemostasis;2016-07-27

5. Structure-function relationships in thrombin-activatable fibrinolysis inhibitor;Journal of Thrombosis and Haemostasis;2016-03-30